当前位置: 首页 > 详情页

Three-Year Clinical Results of Carotid Artery Stenting in Treating Patients with Contralateral Carotid Artery Occlusion

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Vascular Surgery, Xuanwu Hospital, Beijing, China [2]Capital Medical University, Institute of Vascular Surgery, Capital Medical University, Beijing, China [3]Section of Vascular Surgery, Yale University, New Haven, Connecticut [4]Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, Connecticut.
出处:
ISSN:

关键词: Carotid artery occlusion stenting stroke myocardial infarction death

摘要:
Background: Patients presenting a carotid stenosis and contralateral carotid occlusion (CCO) have been historically considered at high risk of carotid surgical treatment, and there are few data regarding short-term recovery after stenting therapy in patients with CCO. The aim of this study is to evaluate the short-term recovery and safety of stenting for patients with CCO and different subgroup population. Methods: We retrospectively reviewed the records of consecutive patients with CCO who were treated with stenting endovascular methods between 2008 and 2014. The postoperative outcomes were analyzed according to age, ischemic symptom, cerebral infarction history, and collateral situation subgroups, respectively. Results: Fifty-eight consecutive patients with CCO were treated and 49 (84.5%) completed a 3-year follow-up. There were significant higher stroke, myocardial infarction, or death events in the aged (>= 75 years old) group and poor collateral group (P =.007 and.0024, respectively). There was no difference in the 3-year primary endpoint incidence between the cerebral ischemia symptom subgroups and cerebral infarction history subgroups. Event-free survival, aged group, and poor collateral group were lower (P =.007 and P =.0024, respectively). Conclusions: Carotid artery stenting (CAS) for patients with common carotid artery is a safe and effective therapy. Factors such as age 75 years or older and poor collateral are associated with a higher 3-year rate of postprocedural stroke, myocardial infarction and death, and lower event-free survival in patients with CCO treated by CAS. Meanwhile, our data do not show a significant impact of cerebral ischemic symptom and cerebral infarction history on clinical outcome of patients with CCO undergoing CAS. (c) 2018 National Stroke Association. Published by Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 神经科学 4 区 外周血管病
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 神经科学 4 区 外周血管病
JCR分区:
出版当年[2016]版:
Q4 PERIPHERAL VASCULAR DISEASE Q4 NEUROSCIENCES
最新[2023]版:
Q3 NEUROSCIENCES Q3 PERIPHERAL VASCULAR DISEASE

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Vascular Surgery, Xuanwu Hospital, Beijing, China [2]Capital Medical University, Institute of Vascular Surgery, Capital Medical University, Beijing, China
通讯作者:
通讯机构: [*1]Department of Vascular Surgery, Xuanwu Hospital, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17010 今日访问量:0 总访问量:909 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院